💊FDA Approval Update | #FDA recently approved #Nuzolvence (#Zoliflodacin) and #Blujepa (#Gepotidacin)
👉For uncomplicated urogenital #gonorrhea
🌟MedChemExpress provides zoliflodacin and gepotidacin for research use only

UK’s health regulator approves new type of antibiotic called Blujepa for UTI Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Click Subscribe #Antibiotic #Healthcare #UTI #Blujepa #MedicalNews

New Antibiotic, Blujepa, May Be Effective in Treating Gonorrhea - Drugs.com MedNews TUESDAY, April 15, 2025 A newly approved antibiotic to treat urinary tract infections may also help fight drug-resistant gonorrhea, a new study shows. The medic

New study shows UTI antibiotic #Blujepa equally effective against drug-resistant gonorrhea as standard treatments. Could be first new gonorrhea treatment in decades! FDA approved for UTIs in March; research published April 14 in The Lancet. www.drugs.com/news/new-ant...

New hope for #UTI sufferers! The FDA approved #Blujepa, a novel antibiotic from #GSK, tackling rising resistance. Learn how this impacts treatment & responsible use. #AntibioticResistance #HealthcareInnovation nomadtabloid.com/article/new-antibiotic-a...

FDA Approves Blujepa for Uncomplicated Urinary Tract Infections - Drugs.com MedNews The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women (wei

Breaking: New UTI Treatment #Blujepa Gets FDA Green Light 🏥
First oral antibiotic specifically approved for uncomplicated urinary tract infections in women and teens (12+ years). Clinical trials revealed impressive results and mild side effects (mostly digestive).

📝Here are my cliff notes for the recently FDA approved drug #gepotidacin #blujepa

www.idstewardship.com/drugs/gepoti...

🤔 Still wondering where the name comes from? It’s a yellow tablet… Kind of sounds like Jet Blue 🤷‍♂️

Anything to add? #IDsky